Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ardelyx, Inc. - Common Stock (NQ:ARDX)

6.060 +1.050 (+20.96%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ardelyx, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
19 20 Next >
The 3 Best Penny Stocks to Buy Now: September 2023
When all the focus lies on the largest names of the economy, these best penny stocks to buy offer a great risk/reward ratio. 
Via InvestorPlace
Topics Economy
Analyst Expectations for Ardelyx's Future
 
Via Benzinga
Ardelyx Showcased Encouraging Data on Treatment Satisfaction and Efficacy of IBSRELA® (tenapanor) for IBS-C at GHAPP 2023
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx to Present at the H.C. Wainwright 25th Annual Global Investment Conference
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx Inc. (NASDAQ: ARDX) is a Stock Spotlight on 8/30
Via Investor Brand Network
Earnings Outlook For Ardelyx
 
Via Benzinga
Recap: Ardelyx Q1 Earnings
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
 
Via Benzinga
Ardelyx, Inc. Reports Employment Inducement Grants
From Ardelyx, Inc.
Via GlobeNewswire
The 3 Most Promising Penny Stocks to Own Now
Explore top penny stock picks, not just whims but for powerhouses poised for exponential growth over the long term. 
Via InvestorPlace
3 Penny Stocks You’ll Regret Not Buying Soon
There are plenty of penny stocks to buy, but not all of them are created equal. Here are some of the best options to choose from. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2023
 
Via Benzinga
Hibbett, American Software, Ardelyx And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Don’t Sleep on These 3 Penny Stocks That Will Mint Millionaires
These top three penny stocks are the ones to buy that will mint your investment status to a millionaire in returns. 
Via InvestorPlace
5 Meme Stocks to Sell Immediately, According to AI
As we move into September, the MarketMaster AI is flashing warning signals about risky equities. Sell these meme stocks right now. 
Via InvestorPlace
Topics Artificial Intelligence
3 Cheap Biotech Stocks That Smart Investors Will Snap Up Now
One of the safest sectors on the market is biotech. Here are three cheap biotech stocks to buy that are good options for investors. 
Via InvestorPlace
Ardelyx Reports Second Quarter 2023 Financial Results and Provides 2023 IBSRELA Net Sales Revenue Guidance
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx, Inc. Reports Employment Inducement Grants
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx to Report Second Quarter 2023 Financial Results on August 2, 2023
Conference call scheduled for 8:00 a.m. Eastern Time 
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx to Present at the H.C. Wainwright 2nd Annual Kidney Conference
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx Announces Acceptance of New Drug Application for Tenapanor for Hyperphosphatemia in China
Acceptance of NDA Submission triggers as $2 million milestone payment to Ardelyx by Fosun Pharma 
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx, Inc. Reports Employment Inducement Grants
From Ardelyx, Inc.
Via GlobeNewswire
Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Ardelyx Stockholders Vote in Favor of Proposed Share Increase
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx to Present at the Jefferies 2023 Healthcare Conference
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx, Inc. Reports Employment Inducement Grants
From Ardelyx, Inc.
Via GlobeNewswire
Why Doximity Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers 
Via Benzinga
Ardelyx Announces FDA Acceptance and Six-Month Review for Resubmission of its New Drug Application of XPHOZAH® (tenapanor)
User Fee Goal Date: October 17, 2023 
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx, Inc. Reports Employment Inducement Grants
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx Presents Positive Data at DDW 2023 on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults
From Ardelyx, Inc.
Via GlobeNewswire
7 High-Potential Penny Stocks in the Biotech Sector
Most of the biggest biotech stocks on the market started off as unknown penny stocks. Here are seven hot ones to consider. 
Via InvestorPlace
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.